Table 1 Patient baseline characteristics
Control | Long duration | P-value | |
|---|---|---|---|
(n = 140) | (n = 116) | ||
Age, y | 54 ± 12 | 55 ± 13 | 0.356 |
Female sex, n (%) | 78 (56%) | 74 (64%) | 0.190 |
Mean AF duration, months | 47 ± 58 | 37 ± 43 | 0.242 |
AF duration ≥ 10 years, n (%) | 16 (11%) | 11 (10%) | 0.614 |
NYHA class III-V, n (%) | 88 (63%) | 68 (59%) | 0.335 |
History of stroke, n (%) | 20 (14%) | 23 (20%) | 0.238 |
Diabetes, n (%) | 9 (6%) | 16 (14%) | 0.048 |
Coronary artery disease, n (%) | 8 (6%) | 12 (10%) | 0.169 |
Hypertension, n (%) | 29 (21%) | 26 (22%) | 0.742 |
Redo operation, n (%) | 8 (6%) | 2 (2%) | 0.118 |
Echocardiographic data | |||
Left atrial diameter, mm | 56 ± 8 | 58 ± 9 | 0.090 |
LVEF, % | 56 ± 9 | 59 ± 9 | 0.051 |
TR grade, moderate to severe | 17 (12%) | 13 (11%) | 0.971 |